{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:35:55Z","timestamp":1777480555763,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2017,5,5]]},"DOI":"10.3233\/cbm-160126","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T11:38:17Z","timestamp":1485257897000},"page":"339-347","source":"Crossref","is-referenced-by-count":8,"title":["MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified"],"prefix":"10.1177","volume":"18","author":[{"given":"Yun","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Hematology, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-160126_ref1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.3233\/CBM-160126_ref2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2015.08.003","article-title":"Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?","volume":"30","author":"Iqbal","year":"2016","journal-title":"Blood Rev"},{"key":"10.3233\/CBM-160126_ref3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1101\/gad.1522907","article-title":"Dynamic regulation of miRNA expression in ordered stages of cellular development","volume":"21","author":"Neilson","year":"2007","journal-title":"Genes Dev"},{"key":"10.3233\/CBM-160126_ref4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00277-014-2188-8","article-title":"Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients","volume":"94","author":"Xu","year":"2015","journal-title":"Ann Hematol"},{"key":"10.3233\/CBM-160126_ref5","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/bcj.2014.34","article-title":"The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas","volume":"4","author":"Briski","year":"2014","journal-title":"Blood Cancer J"},{"key":"10.3233\/CBM-160126_ref6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.path.2015.11.002","article-title":"T-cell Lymphomas: Updates in Biology and Diagnosis","volume":"9","author":"Ondrejka","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"10.3233\/CBM-160126_ref7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3960\/jslrt.55.169","article-title":"Peripheral T-Cell Lymphoma, Not Otherwise Specified and Concurrent Seminoma in Testis","volume":"55","author":"Kitagawa","year":"2015","journal-title":"J Clin Exp Hematop"},{"key":"10.3233\/CBM-160126_ref8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/CBM-160577","article-title":"miR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis","volume":"16","author":"Petrovic","year":"2016","journal-title":"Cancer Biomark"},{"key":"10.3233\/CBM-160126_ref9","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/nar\/gki567","article-title":"Clustering and conservation patterns of human microRNAs","volume":"33","author":"Altuvia","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/CBM-160126_ref10","doi-asserted-by":"crossref","first-page":"970607","DOI":"10.1155\/2014\/970607","article-title":"Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation","volume":"2014","author":"Valinezhad Orang","year":"2014","journal-title":"Int J Genomics"},{"key":"10.3233\/CBM-160126_ref11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"MicroRNAs in cancer","volume":"4","author":"Lee","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.3233\/CBM-160126_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Developmental Biology"},{"key":"10.3233\/CBM-160126_ref13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1389202916666150707160147","article-title":"MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential","volume":"16","author":"Fernandez-Mercado","year":"2015","journal-title":"Curr Genomics"},{"key":"10.3233\/CBM-160126_ref14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/ERC-12-0207","article-title":"miR-1290 and its potential targets are associated with characteristics of estrogen receptor alpha-positive breast cancer","volume":"20","author":"Endo","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.3233\/CBM-160126_ref15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2012.10.038","article-title":"Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells","volume":"329","author":"Wu","year":"2013","journal-title":"Cancer Lett"},{"key":"10.3233\/CBM-160126_ref16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.gene.2015.12.028","article-title":"Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4","volume":"578","author":"Feng","year":"2016","journal-title":"Gene"},{"key":"10.3233\/CBM-160126_ref17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/gcc.22334","article-title":"miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia","volume":"55","author":"Avigad","year":"2016","journal-title":"Genes Chromosomes & Cancer"},{"key":"10.3233\/CBM-160126_ref18","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1101\/gr.2845604","article-title":"MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues","volume":"14","author":"Barad","year":"2004","journal-title":"Genome Res"},{"key":"10.3233\/CBM-160126_ref19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/CBM-160575","article-title":"MicroRNAs contribution in tumor microenvironment of esophageal cancer","volume":"16","author":"Nouraee","year":"2016","journal-title":"Cancer Biomark"},{"key":"10.3233\/CBM-160126_ref20","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/nar\/gkq1043","article-title":"microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma","volume":"39","author":"Imig","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/CBM-160126_ref21","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","article-title":"Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas","volume":"113","author":"Malumbres","year":"2009","journal-title":"Blood"},{"key":"10.3233\/CBM-160126_ref22","doi-asserted-by":"crossref","unstructured":"Endo Y., Yamashita H., Takahashi S., Sato S., Yoshimoto N., Asano T., Hato Y., Dong Y., Fujii Y. and Toyama T., Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer, Bmc Cancer 14 (2014).","DOI":"10.1186\/1471-2407-14-990"},{"key":"10.3233\/CBM-160126_ref23","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.3748\/wjg.v21.i11.3245","article-title":"MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.3233\/CBM-160126_ref24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gene.2016.02.001","article-title":"sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells","volume":"582","author":"Lin","year":"2016","journal-title":"Gene"},{"key":"10.3233\/CBM-160126_ref25","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1158\/1078-0432.CCR-12-3092","article-title":"MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls","volume":"19","author":"Li","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.3233\/CBM-160126_ref26","first-page":"0","article-title":"Leucine Zipper Down-regulated in Cancer-1 (LDOC1) Interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-kappaB) Signaling during Cell Proliferation","author":"Thoompumkal","year":"2016","journal-title":"Cell Cycle"},{"key":"10.3233\/CBM-160126_ref27","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/cam4.772","article-title":"Role of DUSP1\/MKP1 in tumorigenesis, tumor progression and therapy","volume":"5","author":"Shen","year":"2016","journal-title":"Cancer Med"},{"key":"10.3233\/CBM-160126_ref28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbagrm.2014.01.006","article-title":"NF-kappaB target microRNAs and their target genes in TNFalpha-stimulated HeLa cells","volume":"1839","author":"Zhou","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/CBM-160126_ref29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1365-2133.2012.11022.x","article-title":"Expression of microRNAs in basal cell carcinoma","volume":"167","author":"Sand","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.3233\/CBM-160126_ref30","first-page":"715","article-title":"MiR-614 inhibited lung cancer cell invasion and proliferation via targeting PSA","volume":"17","author":"Lv","year":"2014","journal-title":"Zhongguo Fei Ai Za Zhi"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-160126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:34Z","timestamp":1777385314000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-160126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":30,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/cbm-160126","relation":{},"ISSN":["1574-0153","1875-8592"],"issn-type":[{"value":"1574-0153","type":"print"},{"value":"1875-8592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]}}}